On Monday, Cathie Wood-led Ark Invest made a notable move...
October 2, 2023
Ark Invest purchased 92,853 shares of SomaLogic Inc (NASDAQ:SLGC), a notable player in the biotechnology sector through ARKG.
The firm also acquired 45,1942 shares of Recursion Pharmaceuticals (NASDAQ:RXRX), marking a significant addition to its holdings through ARKG.
22,220 shares of Beam Therapeutics Inc (NASDAQ:BEAM) were added to Ark's portfolio, emphasizing its focus on innovative biotech firms through.